Dovitinib is an Orally Active RTK Inhibitor for Kinds of Cancers Research
The multi-targeted receptor tyrosine kinase (RTK) family includes the receptors for insulin and for many growth factors, such as EGF, FGF, PDGF, VEGF, and NGF. Besides, RTKs are transmembrane glycoproteins…